Research ArticleRadiochemistry
Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics
Songye Li, Ming-Qiang Zheng, Mika Naganawa, Sujin Kim, Hong Gao, Michael Kapinos, David Labaree and Yiyun Huang
Journal of Nuclear Medicine July 2019, 60 (7) 1023-1030; DOI: https://doi.org/10.2967/jnumed.118.220517
Songye Li
PET Center, Yale University School of Medicine, New Haven, Connecticut
Ming-Qiang Zheng
PET Center, Yale University School of Medicine, New Haven, Connecticut
Mika Naganawa
PET Center, Yale University School of Medicine, New Haven, Connecticut
Sujin Kim
PET Center, Yale University School of Medicine, New Haven, Connecticut
Hong Gao
PET Center, Yale University School of Medicine, New Haven, Connecticut
Michael Kapinos
PET Center, Yale University School of Medicine, New Haven, Connecticut
David Labaree
PET Center, Yale University School of Medicine, New Haven, Connecticut
Yiyun Huang
PET Center, Yale University School of Medicine, New Haven, Connecticut
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 7
July 1, 2019
Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics
Songye Li, Ming-Qiang Zheng, Mika Naganawa, Sujin Kim, Hong Gao, Michael Kapinos, David Labaree, Yiyun Huang
Journal of Nuclear Medicine Jul 2019, 60 (7) 1023-1030; DOI: 10.2967/jnumed.118.220517
Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics
Songye Li, Ming-Qiang Zheng, Mika Naganawa, Sujin Kim, Hong Gao, Michael Kapinos, David Labaree, Yiyun Huang
Journal of Nuclear Medicine Jul 2019, 60 (7) 1023-1030; DOI: 10.2967/jnumed.118.220517